Edesa Biotech, Inc.EDSANASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank59
3Y CAGR-31.4%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
-31.4%/yr
vs -14.1%/yr prior
Acceleration
-17.3pp
Decelerating
Percentile
P59
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 5.22% |
| Q3 2025 | -29.76% |
| Q2 2025 | -16.16% |
| Q1 2025 | 13.68% |
| Q4 2024 | -89.04% |
| Q3 2024 | 48.02% |
| Q2 2024 | 12.97% |
| Q1 2024 | -19.55% |
| Q4 2023 | 21.62% |
| Q3 2023 | -14.80% |
| Q2 2023 | 14.37% |
| Q1 2023 | -1.36% |
| Q4 2022 | 16.15% |
| Q3 2022 | 51.08% |
| Q2 2022 | -26.72% |
| Q1 2022 | 11.36% |
| Q4 2021 | 5.89% |
| Q3 2021 | 9.68% |
| Q2 2021 | 36.15% |
| Q1 2021 | -263.85% |
| Q4 2020 | -30.01% |
| Q3 2020 | -13.69% |
| Q2 2020 | -16.63% |
| Q1 2020 | -37.13% |
| Q4 2019 | -13.87% |
| Q3 2019 | 26.46% |
| Q2 2019 | 21.57% |
| Q1 2019 | -19.71% |
| Q4 2018 | -18.57% |
| Q3 2018 | -2.39% |
| Q2 2018 | 13.80% |
| Q1 2018 | 3.31% |
| Q4 2017 | -1.53% |
| Q3 2017 | -5.82% |
| Q2 2017 | -12.73% |
| Q1 2017 | 18.87% |
| Q4 2016 | -7.44% |
| Q3 2016 | -10.78% |
| Q2 2016 | -8.44% |
| Q1 2016 | 16.17% |